Minoryx and Neuraxpharm form alliance to get rights to new therapy for rare CNS disease
Minoryx Therapeutics and Neuraxpharm Group have announced a strategic alliance for the European rights to…
November 14, 2022 - 3 minutes
Minoryx Therapeutics
Minoryx and Neuraxpharm announce license agreement to further X-ALD treatment
Minoryx Therapeutics and Neuraxpharm Group have announced the completion of a strategic license agreement. Minoryx…
November 10, 2022 - 3 minutes
Behind the Scenes of the Spanish Biotech Industry’s Boom
The Spanish biotech industry is booming, but from my conversations with industry players elsewhere in…
October 8, 2018 - 5 minutes
Spanish Biotech Raises €21.3M To Advance Rare Disease Pipeline
Rare genetic diseases in the central nervous system may be less of a headache in…
September 26, 2018 - 2 minutes
A New Biotech Hopes to Bring Us the Next Generation of Rare Metabolic Disorder Drugs
Barcelona-based biotech, Minoryx, has spun out Gain Therapeutics to develop the next generation of drugs for…
February 20, 2018 - 3 minutes
And We’re Off! First Patient Dosed in this Spanish Biotech’s Rare Disease Trial
Minoryx Therapeutics has dosed the first patient in its Phase II/III trial for patients with adrenomyeloneuropathy,…
January 8, 2018 - 3 minutes
Meet the CEO of Minoryx, the Spanish Biotech Fighting Rare Disease
I spoke with Marc Martinell, CEO of Minoryx, to learn first-hand how his company in…
July 10, 2017 - 6 minutes
A Potential First Treatment for a Rare Genetic Disease clears Phase I
Minoryx Therapeutics has successfully completed a Phase I trial for its lead compound MIN-102 targeting X-linked adrenoleukodystrophy…
March 21, 2017 - 2 minutes
It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?
We've compiled a list of some of the latest advances of biotech in the field…
February 28, 2017 - 5 minutes
Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017
As BIO Europe Spring 2017 approaches, we decided to take a closer look into biotechs from…
February 22, 2017 - 5 minutes
Spanish connection: VC leads Biotech series A Fund to cure Rare Neurodegenerative Disease
Minoryx Therapeutics is a Barcelona based Rare-disease specialist who has a panel of orphan-drug experts…
October 15, 2015 - 2 minutes
